ALX Oncology Announces New Data Demonstrating Evorpacept in Combination With Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer

GlobeNewswireDec 10 09:00 ET

ALX Oncology to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswireNov 26 08:00 ET

ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner

Zacks Nov 21 08:40 ET

Press Release: ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer

Dow JonesNov 14 08:00 ET

Express News | Cantor Fitzgerald Reiterates Overweight on ALX Oncology Holdings

BenzingaNov 12 08:43 ET

LifeSci Capital Maintains ALX Oncology(ALXO.US) With Hold Rating

Moomoo NewsNov 11 07:34 ET · Ratings